Brendan Horton

Also affiliated with Akebia Therapeutics (United States), Massachusetts Institute of Technology

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras”.

Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras

Cell stem cell(2020)10.1016/j.stem.2020.02.001

N/A

0DataRank · unranked

48 citations

Shupei Zhang, Satyaki Sengupta, Haiting Ma, George W. Bell, Brendan Horton +5 more

1087 Addition of IL-2 overcomes lung tumor resistance to IL-12 by coordinating cytotoxic and regulatory T cell responses

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1087

N/A

0DataRank · unranked

2 citations

Maria Zagorulya, Noor Momin, Yash Agarwal, K Wittrup, Stefani Spranger +1 more

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

Nature Biotechnology(2023)10.1038/s41587-023-01783-y

N/A

0DataRank · unranked

59 citations

Nicolas Mathey‐Andrews, Santiago Naranjo, Samuel I. Gould, Kim L. Mercer, Gregory A. Newby +22 more

Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2

JCI Insight(2023)10.1172/jci.insight.172728

N/A

0DataRank · unranked

26 citations

Alicia D. D’Souza, Maria Zagorulya, Chloe V. McCreery, Gita C. Abhiraman, Lora K. Picton +8 more

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006533

N/A

0DataRank · unranked

20 citations

David A. Braun, Aitziber Buqué, Sarah B. Gitto, Jennifer L. Guerriero, Brendan Horton +9 more

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy

Cell Reports(2024)10.1016/j.celrep.2024.114141

N/A

0DataRank · unranked

23 citations

Brendan Horton, Emily F. Higgs, Ken Hatogai, Anna Martinez, Jason W. Shapiro +5 more